Algae and Microalgae Biotechnology Patents: Sequence Listing Compliance Guide
Introduction Algae and microalgae biotechnology has emerged as one of the most promising fields in modern life sciences, offering innovative solutions for pharmaceuticals, biofuels, nutraceuticals, agriculture, environmental remediation, and sustainable food production. As research in algal genetics, metabolic engineering, and synthetic biology continues to accelerate, inventors are increasingly seeking patent protection for novel biological materials, […]
Sequence Listing Requirements in Patent Reissue Applications: A Comprehensive Guide for Biotechnology Patent Owners
In the rapidly evolving fields of biotechnology, pharmaceuticals, molecular biology and genetic engineering, patent protection often hinges on the accurate disclosure of nucleotide and amino acid sequences. These biological sequences form the backbone of countless innovations, ranging from therapeutic proteins and vaccines to gene-editing technologies and diagnostic methods. Consequently, sequence listings are not merely supplementary […]
Bispecific Antibody Patents: How to Prepare Compliant Sequence Listings
Introduction Bispecific antibodies represent one of the most important advances in modern biologics, enabling a single molecule to bind two distinct antigens or epitopes simultaneously. This dual-targeting capability has led to major therapeutic breakthroughs in oncology, immunology, and infectious diseases, and has consequently triggered a rapid increase in global patent filings. However, patent protection for […]
What Happens During EPO Examination of Sequence Listings?
Introduction In biotechnology and life sciences patenting, sequence listings are not a peripheral formality – they are a critical technical and legal artifact that can influence both the efficiency of examination and the enforceability of resulting patent rights. At the European Patent Office (EPO), sequence listings are treated as structured technical data rather than narrative […]
Step-by-Step WIPO Sequence Software Tutorial for First-Time Users
The WIPO Sequence software is an official desktop application developed by the World Intellectual Property Organization to help applicants prepare patent sequence listings that comply with WIPO Standard ST.26. It is widely used in biotechnology and life sciences patent drafting where nucleotide and amino acid sequences must be submitted in a structured XML format. Unlike […]
Antibody-Drug Conjugate (ADC) Sequence Listing: Patent Filing Best Practices
Antibody-Drug Conjugates (ADCs) represent one of the most advanced classes of targeted therapeutics, combining the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As ADC innovation accelerates, patent protection – particularly the accurate preparation of sequence listings – has become a critical component of intellectual property strategy. This article outlines best practices for […]
Antibody-Drug Conjugate (ADC) Sequence Listing: Patent Filing Best Practices
Antibody-Drug Conjugates (ADCs) represent one of the most advanced classes of targeted therapeutics, combining the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As ADC innovation accelerates, patent protection – particularly the accurate preparation of sequence listings – has become a critical component of intellectual property strategy. This article outlines best practices for […]
Nanobody and Single-Domain Antibody Sequence Listings: Patent Disclosure Requirements
Introduction The rapid advancement of antibody engineering has transformed the landscape of biologic therapeutics. Among the most significant innovations are nanobodies and single-domain antibodies (sdAbs), which offer unique structural and functional advantages over conventional monoclonal antibodies. Their small size, exceptional stability, high tissue penetration and ease of manufacturing have led to widespread applications in therapeutics, […]
EPO National Phase Sequence Listing: Transitioning from PCT to European Patent
Introduction For biotechnology, pharmaceutical, agricultural biotechnology, and life sciences innovators, international patent protection frequently begins with a Patent Cooperation Treaty (PCT) application. However, obtaining enforceable patent rights in Europe requires a critical next step: entering the European regional phase before the European Patent Office (EPO). One of the most important considerations during this transition involves […]
Concatemer and Multi-Domain Protein Sequence Listings: Advanced Patent Disclosure Guide
Biotechnology patent drafting becomes especially demanding when dealing with concatemers and multi-domain proteins because the invention is no longer just described—it is encoded as a legally binding biological sequence structure. In these cases, the sequence listing is not supporting material; it is the core definition of the invention itself. The United States Patent and Trademark […]